Objective: This study aimed to evaluate the efficacy and safety of 0.5% timolol maleate gel, reported as an efficacious option for management of infantile hemangiomas (IH) in children.
Methods: A retrospective study was conducted among patients diagnosed with IH from January 2019 to December 2021.